GURUFOCUS.COM » STOCK LIST » Consumer Defensive » Tobacco Products » Hempacco Co Inc (NAS:HPCO) » Definitions » Capex-to-Revenue

Hempacco Co (Hempacco Co) Capex-to-Revenue : 0.01 (As of Sep. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Hempacco Co Capex-to-Revenue?

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue.

Hempacco Co's Capital Expenditure for the three months ended in Sep. 2023 was $-0.02 Mil. Its Revenue for the three months ended in Sep. 2023 was $1.33 Mil.

Hence, Hempacco Co's Capex-to-Revenue for the three months ended in Sep. 2023 was 0.01.


Hempacco Co Capex-to-Revenue Historical Data

The historical data trend for Hempacco Co's Capex-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hempacco Co Capex-to-Revenue Chart

Hempacco Co Annual Data
Trend Dec20 Dec21 Dec22
Capex-to-Revenue
0.15 0.07 0.03

Hempacco Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Capex-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.27 -0.13 0.09 0.44 0.01

Competitive Comparison of Hempacco Co's Capex-to-Revenue

For the Tobacco subindustry, Hempacco Co's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hempacco Co's Capex-to-Revenue Distribution in the Tobacco Products Industry

For the Tobacco Products industry and Consumer Defensive sector, Hempacco Co's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where Hempacco Co's Capex-to-Revenue falls into.



Hempacco Co Capex-to-Revenue Calculation

Hempacco Co's Capex-to-Revenue for the fiscal year that ended in Dec. 2022 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.104) / 3.967
=0.03

Hempacco Co's Capex-to-Revenue for the quarter that ended in Sep. 2023 is calculated as

Capex-to-Revenue=- Capital Expenditure / Revenue
=- (-0.015) / 1.326
=0.01

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Hempacco Co  (NAS:HPCO) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.


Hempacco Co Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of Hempacco Co's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Hempacco Co (Hempacco Co) Business Description

Traded in Other Exchanges
N/A
Address
9925 Airway Road, San Diego, CA, USA, 92154
Hempacco Co Inc is engaged in manufacturing and selling nicotine-free and tobacco-free alternatives to traditional cigarettes. It utilizes a proprietary, patented spraying technology for terpene infusion and patent-pending flavored filter infusion technology to manufacture hemp and herb-based smokable alternatives. The company's operating segments include private label manufacturing and sales, intellectual property licensing, and the development and sales of inhouse brands using patented counter displays.
Executives
Stuart W Titus director 2015 S. TUTTLE AVE A, SARASOTA FL 34239
Sandro Piancone director, 10 percent owner, officer: CEO & President 826 SCENIC TERRANCE PLACE, CHULA VISTA CA 92154
Neville Pearson officer: Chief Financial Officer 9925 AIRWAY ROAD, SAN DIEGO CA 92154
Miki Stephens director 9925 AIRWAY ROAD, SAN DIEGO CA 92154
Jerry Halamuda director 9925 AIRWAY ROAD, SAN DIEGO CA 92154